IP Library Granted Patent US 7,329,489
Granted Patent B2
US 7,329,489 · App. 10/695,265 · Granted Feb 12, 2008

Methods for drug discovery, disease treatment, and diagnosis using metabolomics

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,329,489
App. No.
10/695,265
Granted
Feb 12, 2008
Kind
B2
Abstract

The small molecule profiles of cells are compared to identify small molecules which are modulated in altered states. Cellular small molecule libraries, methods of identifying tissue sources, methods for treating genetic and non-genetic diseases, and methods for predicting the efficacy of drugs are also discussed.

Claims (90)

1. A method for metabolomically identifying small molecules indicative of amyotrophic lateral sclerosis, comprising:

obtaining a small molecule profile from a subject suffering from amyotrophic lateral sclerosis; and

comparing the small molecule profile from the subject to a standard small molecule profile, thereby identifying small molecules indicative of amyotrophic lateral sclerosis, wherein said small molecule profile is obtained using one or more techniques which detect 50% or more of the small molecules in said sample.

2. The method of claim 1 , wherein said subject is a human.

3. The method of claim 1 , wherein said small molecule profile is obtained from said subject's tissue.

4. The method of claim 1 , wherein said small molecule profile is obtained using one or more of the following: HPLC, TLC, electrochemical analysis, mass spectroscopy, refractive index spectroscopy (RI), Ultra-Violet spectroscopy (UV), fluorescent analysis, gas chromatography (GC), radiochemical analysis, Near-InfraRed spectroscopy (Near-IR), Nuclear Magnetic Resonance spectroscopy (NMR), and Light Scattering analysis (LS).

5. A method for metabolomically identifying small molecules indicative of Parkinson's disease, comprising:

obtaining a small molecule profile from a subject suffering from Parkinson's disease; and

comparing the small molecule profile from the subject to a standard small molecule profile, thereby identifying small molecules indicative of Parkinson's disease, wherein said small molecule profile is obtained using one or more techniques which detect 50% or more of the small molecules in said sample.

6. A method for metabolomically identifying small molecules indicative of schizophrenia, comprising:

obtaining a small molecule profile from a subject suffering from schizophrenia; and

comparing the small molecule profile from the subject to a standard small molecule profile, thereby identifying small molecules indicative of schizophrenia, wherein said small molecule profile is obtained using one or more techniques which detect 50% or more of the small molecules in said sample.

7. A method for metabolomically identifying small molecules indicative of Parkinson's disease, comprising:

obtaining a small molecule profile from a subject suffering from Parkinson's disease; and

comparing the small molecule profile from the subject to a standard small molecule profile, thereby identifying small molecules indicative of Parkinson's disease, wherein small molecule profile is obtained using one or more techniques which detect 50% or more of the small molecules in said sample.

8. A method for metabolomically identifying small molecules indicative of depression, comprising:

obtaining a small molecule profile from a subject suffering from depression; and

comparing the small molecule profile from the subject to a standard small molecule profile, thereby identifying small molecules indicative of depression, wherein said small molecule profile is obtained using one or more techniques which detect 50% or more of the small molecules in said sample.

9. A method for metabolomically identifying small molecules indicative of schizophrenia, comprising:

obtaining a small molecule profile from a subject suffering from schizophrenia; and

comparing the small molecule profile from the subject to a standard small molecule profile, thereby identifying small molecules indicative of schizophrenia, wherein small molecule profile is obtained using one or more techniques which detect 50% or more of the small molecules in said sample.

10. The method of claim 4 , wherein said small molecule profiles is obtained from said subject's cells, cellular organelles, interstitial fluid, or saliva.

11. The method of claim 5 , wherein said subject is a human.

12. The method of claim 5 , wherein said small molecule profiles is obtained from said subject's tissue.

13. The method of claim 5 , wherein said small molecule profiles is obtained from said subject's cells, cellular organelles, interstitial fluid, or saliva.

14. The method of claim 5 , wherein said small molecule profiles is obtained using one or more of the following: HPLC, TLC, electrochemical analysis, mass spectroscopy, refractive index spectroscopy (RI), Ultra-Violet spectroscopy (UV), fluorescent analysis, radiochemical analysis, Near-InfraRed spectroscopy (Near-IR), Nuclear Magnetic Resonance spectroscopy (NMR), gas chromatography (GC) and Light Scattering analysis (LS).

15. The method of claim 6 , wherein said subject is a human.

16. The method of claim 6 , wherein said small molecule profiles is obtained from said subject's tissue.

17. The method of claim 6 , wherein said small molecule profiles is obtained from said subject's cells, cellular organelles, interstitial fluid, or saliva.

18. The method of claim 6 , wherein said small molecule profiles is obtained using one or more of the following: HPLC, TLC, electrochemical analysis, mass spectroscopy, refractive index spectroscopy (RI), Ultra-Violet spectroscopy (UV), fluorescent analysis, radiochemical analysis, Near-InfraRed spectroscopy (Near-IR), Nuclear Magnetic Resonance spectroscopy (NMR), gas chromatography (GC) and Light Scattering analysis (LS).

19. The method of claim 7 , wherein said subject is a human.

20. The method of claim 7 , wherein said small molecule profiles is obtained from said subject's tissue.

21. The method of claim 7 , wherein said small molecule profiles is obtained from said subject's cells, cellular organelles, interstitial fluid, or saliva.

22. The method of claim 7 , wherein said small molecule profiles is obtained using one or more of the following: HPLC, TLC, electrochemical analysis, mass spectroscopy, refractive index spectroscopy (RI), Ultra-Violet spectroscopy (UV), fluorescent analysis, radiochemical analysis, Near-InfraRed spectroscopy (Near-IR), Nuclear Magnetic Resonance spectroscopy (NMR), gas chromatography (GC) and Light Scattering analysis (LS).

23. The method of claim 8 , wherein said subject is a human.

24. The method of claim 8 , wherein said small molecule profiles is obtained from said subject's tissue.

25. The method of claim 8 , wherein said small molecule profiles is obtained from said subject's cells, cellular organelles, interstitial fluid, or saliva.

26. The method of claim 8 , wherein said small molecule profiless is obtained using one or more of the following: HPLC, TLC, electrochemical analysis, mass spectroscopy, refractive index spectroscopy (RI), Ultra-Violet spectroscopy (UV), fluorescent analysis, radiochemical analysis, Near-InfraRed spectroscopy (Near-IR), Nuclear Magnetic Resonance spectroscopy (NMR), gas chromatography (GC) and Light Scattering analysis (LS).

27. The method of claim 9 , wherein said subject is a human.

28. The method of claim 9 , wherein said small molecule profiles is obtained from said subject's tissue.

29. The method of claim 9 , wherein said small molecule profiles is obtained from said subject's cells, cellular organelles, interstitial fluid, or saliva.

30. The method of claim 9 , wherein said small molecule profiles is obtained using one or more of the following: HPLC, TLC, electrochemical analysis, mass spectroscopy, refractive index spectroscopy (RI), Ultra-Violet spectroscopy (UV), fluorescent analysis, radiochemical analysis, Near-InfraRed spectroscopy (Near-IR), Nuclear Magnetic Resonance spectroscopy (NMR), gas chromatography (CC) and Light Scattering analysis (LS).

31. The method of claim 4 , wherein said small molecule profile is obtained from said subject's biological fluids.

32. The method of claim 1 , wherein said small molecule profile is obtained using mass spectroscopy.

33. The method of claim 1 , wherein said small molecule profile is obtained using gas chromatography (GC).

34. The method of claim 1 , wherein said small molecule profile is obtained using Nuclear Magnetic Resonance spectroscopy (NMR).

35. The method of claim 1 , wherein said small molecule profile is obtained using HPLC.

36. The method of claim 4 , wherein said small molecule profile is obtained from said subject's spinal fluid.

37. The method of claim 4 , wherein said small molecule profiles are obtained from said subject's serum.

38. The method of claim 4 , wherein said small molecule profile is obtained from said subject's urine.

39. The method of claim 5 , wherein said small molecule profile is obtained from said subject's biological fluids.

40. The method of claim 14 , wherein said small molecule profile is obtained using mass spectroscopy.

41. The method of claim 14 , wherein said small molecule profile is obtained using gas chromatography (GC).

42. The method of claim 14 , wherein said small molecule profile is obtained using Nuclear Magnetic Resonance spectroscopy (NMR).

43. The method of claim 14 , wherein said small molecule profile is obtained using HPLC.

44. The method of claim 5 , wherein said small molecule profiles are obtained from said subject's serum.

45. The method of claim 5 , wherein said small molecule profile is obtained from said subject's urine.

46. The method of claim 5 , wherein said small molecule profile is obtained from said subject's spinal fluid.

47. The method of claim 6 , wherein said small molecule profile is obtained from said subject's biological fluids.

48. The method of claim 18 , wherein said small molecule profile is obtained using mass spectroscopy.

49. The method of claim 18 , wherein said small molecule profile is obtained using gas chromatography (GC).

50. The method of claim 18 , wherein said small molecule profile is obtained using Nuclear Magnetic Resonance spectroscopy (NMR).

51. The method of claim 18 , wherein said small molecule profile is obtained using HPLC.

52. The method of claim 6 , wherein said small molecule profile is obtained from said subject's spinal fluid.

53. The method of claim 6 , wherein said small molecule profiles are obtained from said subject's serum.

54. The method of claim 6 , wherein said small molecule profile is obtained from said subject's urine.

55. The method of claim 7 , wherein said small molecule profile is obtained from said subject's biological fluids.

56. The method of claim 22 , wherein said small molecule profile is obtained using mass spectroscopy.

57. The method of claim 22 , wherein said small molecule profile is obtained using gas chromatography (GC).

58. The method of claim 22 , wherein said small molecule profile is obtained using Nuclear Magnetic Resonance spectroscopy (NMR).

59. The method of claim 22 , wherein said small molecule profile is obtained using HPLC.

60. The method of claim 7 , wherein said small molecule profile is obtained from said subject's spinal fluid.

61. The method of claim 7 , wherein said small molecule profiles are obtained from said subject's serum.

62. The method of claim 7 , wherein said small molecule profile is obtained from said subject's urine.

63. The method of claim 8 , wherein said small molecule profile is obtained from said subject's biological fluids.

64. The method of claim 26 , wherein said small molecule profile is obtained using mass spectroscopy.

65. The method of claim 26 , wherein said small molecule profile is obtained using gas chromatography (GC).

66. The method of claim 26 , wherein said small molecule profile is obtained using Nuclear Magnetic Resonance spectroscopy (NMR).

67. The method of claim 26 , wherein said small molecule profile is obtained using HPLC.

68. The method of claim 8 , wherein said small molecule profile is obtained from said subject's spinal fluid.

69. The method of claim 8 , wherein said small molecule profiles are obtained from said subject's serum.

70. The method of claim 8 , wherein said small molecule profile is obtained from said subject's urine.

71. The method of claim 9 , wherein said small molecule profile is obtained from said subject's biological fluids.

72. The method of claim 30 , wherein said small molecule profile is obtained using mass spectroscopy.

73. The method of claim 30 , wherein said small molecule profile is obtained using gas chromatography (GC).

74. The method of claim 30 , wherein said small molecule profile is obtained using Nuclear Magnetic Resonance spectroscopy (NMR).

75. The method of claim 30 , wherein said small molecule profile is obtained using 1 {PLC.

76. The method of claim 9 , wherein said small molecule profile is obtained from said subject's spinal fluid.

77. The method of claim 9 , wherein said small molecule profiles are obtained from said subject's serum.

78. The method of claim 9 , wherein said small molecule profile is obtained from said subject's urine.

Assignments (11)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR'S NAME FROM " PERCEPTIVE CREDIT HOLDINGS ILL, LP" TO "PERCEPTIVE CREDIT HOLDINGS III, LP" PREVIOUSLY RECORDED AT REEL: 66971 FRAME: 0054. ASSIGNOR(S) HEREBY CONFIRMS THE RELEASE OF SECURITY INTEREST. Recorded Apr 4, 2024
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: METABOLON, INC.
Reel/Frame 067019/0662 →
RELEASE OF SECURITY INTEREST Recorded Apr 1, 2024
From: PERCEPTIVE CREDIT HOLDINGS ILL, LP
To: METABOLON, INC.
Reel/Frame 066971/0054 →
SECURITY AGREEMENT Recorded Jul 24, 2020
From: METABOLON, INC.
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 053313/0406 →
RELEASE OF SECURITY INTEREST Recorded Jul 23, 2020
From: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
To: METABOLON, INC.
Reel/Frame 053290/0441 →
SECURITY INTEREST Recorded Jun 10, 2020
From: METABOLON, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 052902/0736 →
RELEASE OF SECURITY INTEREST Recorded Jul 10, 2018
From: MIDCAP FUNDING IV TRUST
To: METABOLON, INC.; LACM, INC.
Reel/Frame 047247/0568 →
RELEASE OF SECURITY INTEREST Recorded Jul 10, 2018
From: MIDCAP FUNDING IV TRUST
To: METABOLON, INC.; LACM, INC.
Reel/Frame 047247/0658 →
SECURITY INTEREST (TERM LOAN) Recorded Jun 15, 2016
From: METABOLON, INC.; LACM, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 039024/0396 →
SECURITY INTEREST (REVOLVING LOAN) Recorded Jun 15, 2016
From: METABOLON, INC.; LACM, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 039024/0422 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2007
From: KADDURAH-DAOUK, RIMA
To: METABOLON, INC.
Reel/Frame 019503/0977 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2007
From: KRISTAL, BRUCE S.
To: CORNELL RESEARCH FOUNDATION, INC.
Reel/Frame 019373/0370 →